TrialThe oncologist2021

EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.

Julio Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.